Typhoid IgG/IgM Rapid Test - India CDSCO Medical Device Registration

Typhoid IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2018/000034_5cfd1dfb634249e0dacd60c3617152e0_3f728da3c082a9fbc21efd9c6f299ff7. This device is marketed under the brand name Colloidal Gold. The license holder is APEX DIAGNOSTICS, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Typhoid IgG/IgM Rapid Test

UID: IMP/IVD/2018/000034_5cfd1dfb634249e0dacd60c3617152e0_3f728da3c082a9fbc21efd9c6f299ff7

Brand Name

Colloidal Gold

License Holder

APEX DIAGNOSTICS

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (Colloidal Gold) IgG and IgM in human serum and plasma . It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM Rapid Test must be confirmed with alternative testing method(Colloidal Gold)